Related by context. Frequent words. (Click for all words.) 82 Phase IIb 79 Phase 2a 78 Phase III 77 Phase 2b study 77 Phase 2b clinical 77 Phase IIb clinical 76 Phase III clinical 76 pivotal Phase III 76 Phase 2b trial 76 Phase 1b 75 Phase Ib 75 Phase IIa 75 Phase 2a clinical 74 Phase IIa trial 73 pivotal Phase 73 Phase IIb trial 73 Phase IIa clinical 72 Phase II 69 randomized Phase 69 Phase III trials 68 Phase III clinical trials 66 PRX # 66 Phase 65 INCB# [002] 64 placebo controlled 64 blind randomized placebo 64 clinical trial 64 dose escalation study 63 randomized placebo controlled 63 AP# [003] 63 ISIS # 63 multicenter 63 double blind placebo 62 MGCD# [001] 62 dose escalation 61 tolerability 61 ARRY 61 preclinical 61 investigational compound 61 CRx 61 RDEA# 61 XL# [003] 61 ASA# 61 mipomersen 61 randomized double 61 ofatumumab 60 AEZS 60 RG# [001] 60 IMGN# 60 ADX# 60 clinical trials 59 blind randomized 59 HspE7 59 perifosine 59 initiate Phase 59 tivozanib 59 Marqibo 59 LymphoStat B 59 linaclotide 58 prospective randomized 58 Locteron 58 voreloxin 58 randomized clinical 58 carfilzomib 58 IDX# 58 randomized controlled 58 monotherapy 58 LEVADEX 57 NDA submission 57 pharmacokinetic 57 investigational drug 57 hormone refractory prostate cancer 57 T DM1 57 picoplatin 57 ALKS 57 preclinical studies 57 Bronchitol 57 safety tolerability 57 FOLOTYN 57 Defibrotide 56 ITMN 56 AMR# 56 laquinimod 56 ACTEMRA 56 daclizumab 56 New Drug Application 56 MDV# 56 NKTR 56 Tovaxin 56 kinase inhibitor 56 SPP# [001] 56 APF# 56 CYT# 56 ISA# [002] 56 AZD# 56 pharmacodynamic 56 unblinded 55 tolerability profile 55 blind placebo controlled 55 randomized 55 pharmacodynamics